45S5 BIOACTIVE GLASS BIBLIOGRAPHY

  1. “ Poster#390,ORS 2017 Annual Meeting”, San Diego, California, March 19-22.
  2.  “Bioglass is back– In an Incredible New Form. Robin Young”, Orthopedics This Week. Thu, October 16th, 2014.
  3.  “A new synthesis route to high surface area sol gel bioactive glass through alcohol washing: a preliminary study”, Mukundan LM, Nirmal R, Vaikkath D, Nair PD. Biomatter. 2013 Apr-Jun;3(2). e24288-1 to e24288-10.
  4.  “Chronology of Bioactive Glass Development and Clinical Applications” Larry L. Hench, New Journal of Glass and Ceramics, 2013, 3, 67-73.
  5.  “Bioactive glass in tissue engineering”, Mohamed N. Rahaman, Delbert E. Day, B. Sonny Bal, Qiang Fu, Steven B. Jung, Lynda F. Bonewald, and Antoni P. Tomsia, Acta Biomater. 2011 June ; 7(6): 2355–2373.
  6.  “Development and Applications of Varieties of Bioactive Glass Compositions in Dental Surgery, Third Generation Tissue Engineering, Orthopaedic Surgery and as Drug Delivery System”, Samit Kumar Nandi, Biswanath Kundu and Someswar Datta, Chapter 4, Biomaterials Applications for Nanomedicine. Edited by Rosario Pignatello, ISBN 978-953-307-661-4, 470 pages, Publisher: InTech, Chapters published November 16, 2011 under CC BY 3.0 license.
  7.  “Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering”, Lutz-Christian Gerhardt and Aldo R. Boccaccini, Materials 2010, 3, 3867-3910.
  8.  “Enhanced osteocalcin expression by osteoblast-like cells (MC3T3-E1) exposed to bioactive coating glass (SiO2-CaO-P2O5-MgO-K2O-Na2O system) ions”, Varanasi VG1, Saiz E, Loomer PM, Ancheta B, Uritani N, Ho SP, Tomsia AP, Marshall SJ, Marshall GW, Acta Biomater. 2009 Nov;5(9):3536-47.
  9.  “Genetic design of bioactive glass” Larry L. Hench, Journal of the European Ceramic Society, 29 (2009) 1257–1265.
  10.  “Bioactive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis; a comparative study with iliac crest autograph”, Ilharreborde B, Morel E, Fitoussi F, et al… J Pediatr Orthop 2008:28;347-351.
  11. “Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds” Brown RF1, Day DE, Day TE, Jung S, Rahaman MN, Fu Q, Acta Biomater. 2008 Mar;4(2):387-96.
  12.  “Antimicrobial effect of nanometric bioactive glass 45S5”, Waltimo T, Brunner TJ, Vollenweider M, Stark WJ, Zehnder M. J Dent Res. 2007 Aug;86(8):754-7.
  13.  “Bioactive Glass Scaffolds for Bone Regeneration”, Julian R. Jones, Eileen Gentleman and Julia Polak, Elements, Vol. 3, PP 393-399, December 2007.
  14.  “Optimising bioactive glass scaffolds for bone tissue engineering”, Julian R. Jones, Lisa M. Ehrenfried, Larry L. Hench, Biomaterials 27 (2006) 964–973.
  15.  “Bioglass®: A short history and bibliography”, L. L. Hench, June W. Hench and D. C. Greenspan, J. Aust. Ceram. Soc., [40], 1, 2004, pages 1-42.
  16.  “Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths”, Gough JE, Notingher I, Hench LL, J Biomed Mater Res A. 2004 Mar 15;68(4):640-50.
  17.  “Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study”, R Mengel, M Soffner, L Flores-de-Jacoby, J Periodontol, 74;6:899-908, June (2003).
  18.  “Indirect cytotoxicity evaluation of soluble silica, calcium and phosphate ions”, J. Selvakumaran, P.Saravanapavan and L.L. Hench, Bioceramics 16 International Symposium on Ceramics in Medicine (2003).
  19.  “Bioactive Materials for Tissue Engineering Scaffolds”, Larry L Hench, Julian R Jones, Pilar Sepulveda, Chapter 1. Future Strategies for Tissue and Organ Replacement, Edited by: Julia M Polak, Larry L Hench, P Kemp , 448pp, May 2002. ISBN: 978-1-86094-964-7.
  20.  “Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution”, Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM, J Biomed Mater Res. 2001 May;55(2):151-7.
  21. “Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering”, Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM, Calcif Tissue Int. 2000 Oct;67(4):321-9.
  22.  “A bioactive glass particulate in the treatment of molar furcation invasion”, CR Anderegg, DC Alexander, M Freidman, (1999)J Periodontol, 70; 4:384-7.
  23.  “Histologic Observations of Periodontal Wound Healing After Treatment with PerioGlas™ in Non-Human Primates,” S. Karatzas, A. Zavras, D. Greenspan, S. Amar, (1999) Intl J Perio Res Den, Vol. 19 (5).
  24.  “Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans”, TB Lovelace, JT Mellonig, RM Meffert, AA Jones, PV Nummikoski, DL Cochran, J Periodontol, (1998) 69; 9:1027-35.
  25.  “Comparison of Bioglass® Synthetic Bone Graft Particles and Open Debridement in the Treatment of Human Periodontal Defects”, S.J. Froum , S.C. Cho, E. Rosenberg, M. Roher, and D. Tarnow, J. Perio; (1998) 69:698-709.
  26.  “An evaluation of bioactive ceramic in the treatment of periodontal osseous defects”, SB Low, CJ King, J Krieger, Int J Periodontics Restorative Dent, 17;4:358-67, August (1997).
  27.  “Analysis of the chemical transformation of bioactive glass particles after implantation”, E Schepers, L Barbier, A Huygh, P Ducheyne, J Oral Rehabilitation, 24: 171-181, (1997).
  28.  “Behavior of Bioactive Glass (S53P4) in Human Frontal Sinus Obliteration”, K Aitasalo, J Suonpaa, M Peltola, A Yli-Urpo, Bioceramics, 10: 429-32, October (1997).
  29. “Clinical use of a bioactive glass particulate in the treatment of human osseous defects”, CA Shapoff, DC Alexander, AE Clark, Compend Contin Educ Dent, 18;4:352-4, April (1997).
  30.  “Particulate Bioglass® Compared with Hydroxyapatite as a Bone Graft Substitute,” H. Oonishi, S. Kutrshitani, E. Yasukawa, H. Iwaki, L. L. Hench, J. Wilson, E. Tsuji, and T. Sugihara, J. Clinical Orthopaedics and Related Research, 334 (1997), 316-325.
  31.  “Using 45S5 Bioglass® Cones as Endosseous Ridge Maintenance Implants to Prevent Alveolar Ridge Resorption: A 5-Year Evaluation,” Harold R. Stanley, Matthew B. Hall, Arthur E. Clark, Caleb J. King III, Larry L. Hench, Joseph J. Berte, Int. J. Oral Maxillofac. Implants, 12 (1997), 95-105.
  32.  “Ossicular Replacement Prostheses”, K. Lobel, in Clinical Performance of Skeletal Prostheses, Hench and Wislon (eds), Chapman and Hall, Ltd, London, (1996), pp. 214-236.
  33.  “Alveolar Ridge Maintenance Implants” H.R.Stanley, A.E.Clark, June Wilson and L.L.Hench. Clinical Performance of Skeletal Prostheses. L.L.Hench and June Wilson, Eds. Chapman and Hall, Publishers,London, England (1995).
  34.  “Bioglass® Middle Ear Devices: Ten year Clinical Results” June Wilson, Ellis Douek and Kevin Rust. Bioceramics 8, (1995) June Wilson, L.L.Hench and D. Greenspan, Eds. Elsevier Science, Oxford, England, Publishers.
  35. “Bone Growth into Spaces Between 45S5 Bioglass® Granules,” H. Oonishi, S. Kushitani, E. Yasukawa, H. Kawakami, A. Nakata, S. Koh, L. L. Hench, J. Wilson, E. Tsuji, and T. Sugihara, in Bioceramics 7, Ö. H. Andersson and A. Yli-Urpo, eds., Butterworth-Heinemann Ltd., Oxford, England (1994), 139-144.
  36.  “Periodontal Repair Using Perioglas® in NonHuman Primates: Clinical and Histologic Observations”, A.E. Fetner, M.S. Hartigan, S.B.Low, Compendium Contin Educ Dent, 15(7), 932-939, 1994.
  37.  “Tissue Response to Bioglass® Endosseous Ridge Maintenance Implants,” June Wilson, A. E. Clark, M. Hall and L. L. Hench, J. Oral Implantology, XIX[4], (1993), 295-302.
  38.  “Bioactive Ceramics for Periodontal Treatment: Comparative Studies.” June Wilson and S.B.Low. J.Applied Biomaterials, Vol.3, (1992) 123-129.
  39.  “Bioactive glass particulate material as a filler for bone lesions”, E Schepers, M de Clercq, P Ducheyne, Journal of Oral Rehabilitation, 18: 439-452, (1991).
  40.  “Otologic Applications of Bioglass® Implants,” E. Douek, in Proceedings of IVth International Symposium on Bioceramics in Medicine. Edited by W. Bonfield, London, Sept. 10-11, (1991).
  41.  “Bonding of Soft Tissues to Bioglass®”, J. Wilson and D. Noletti in Handbook of Bioactive Ceramics Vol. 1: bioactive Galsses and Glass-Ceramics, T. Yamamuro, L.L. Hench and J. Wilson, eds., CRC Press, Boca Raton, FL (1990).
  42.  “Review of Bioactive Materials for Otologic and Maxillofacial Applications”; G. E. Merwin, in Handbook of Bioactive Ceramics, Vol I. Edited by T. Yamamuro, L. L. Hench and J. Wilson. CRC Press, Boca Raton, FL, (1990), pp. 323-328.
  43.  “Bioactive Materials for Periodontal Treatment: A Comparative Study,” J. Wilson, S. Low, A. Fetner and L. L. Hench in Biomaterials and Clinical Applications, A. Pizzoferrato, P. G. Marchetti, A. Ravaglioli and A.J.C. Lee, eds., Elsevier Science Publishers, Amsterdam, (1987), 223-228.
  44.  “Early Clinical Trials of 45S5 Bioglass® for Endosseous Ridge Maintenance with a New Endosseous Implant Material”, M.B. Hall, H.R. Stanley, C.King, F. Colaizzi, D. Spilman and L.L. Hench, J. Prosthetic Dentistry, 58 [5] (1987), 607-613.
  45.  “Residual Alveolar Ridge Maintenance With a New Endosseous Implant Material”, H.R. Stanley, M.B. Hall, F. Colaizzi and A.E. Clark, Jr. in Maxillofacial Prosthetics, Dental Implants,K. Adisman, and R.P. Desjardins, eds. J. Prosthetic Dentistry 58 [5] (1987).
  46.  “Bioglass® middle ear prosthesis: preliminary report”, GE Merwin, Ann Otol Rhinol Laryngol, 95; 1 Pt 1:78-82 January-February (1986).
  47.  “Facial Bone Augmentation Using Bioglass® in Dogs”, J. Wilson, G. Merwin,L. Rogers, D.Spilman and R. Martin, in Surgical Research Recent Development, Proc. 1st Annual Scientific Session of Acad. Of Surgical Res., C. W. Hall, ed. Pergamon Press, (1985), 66-70.
  48.  “Histopathological Evaluation of Interaction between Tympanic Membrane and Implant Materials”, June Wilson, J.S.Atkins, G.E.Merwin and L.L.Hench. Trans. Soc. For Biomat. Vol.8 195, 1985.
  49.  “Tissue Response to Surface Active Material”, J. Wilson and L. L. Hench, in The Dental Implant, R.V. McKinney Jr and J.E. Lemons eds., PSG Publishing Co. (1985) 181-196.
  50.  “Bioglass Implants for Otology,” L. L. Hench, June Wilson and G. Merwin in Biomaterials in Otology, J. J. Grote, ed., Martinus Nijhoff Publishers, The Hague-Boston-London, 1983.
  51.  “Comparison of Ossicular Replacement Materials in a Mouse Ear Model,” Gerald E. Merwin, James S. Atkins, June Wilson, Larry L. Hench, Otolaryngol. Head Neck Surg., 90 (1982) 461-469.
  52.  “The Implantation of Natural Tooth Form Bioglass® in Baboons – Long Term Results,” H. R. Stanley, L. L. Hench, C. G. Bennett, Jr., S. J. Chellemi, C. J. King, III, R. E. Going, N. J. Ingersoll, E. C. Ethridge, K. L. Kreutziger, L. Loeb, and A. E. Clark, Intern. J. Oral Implantology 2 (1981) 26-36.
  53.  “Toxicology and Biocompatibility of Bioglasses®,” J. Wilson, G. H. Pigott, F. J. Schoen and L. L. Hench, J. Biomed. Maters. Res. 15 (1981) 805-817.
  54.  “Implantation of Natural Tooth Form Bioglasses in Baboon”, H.R. Stanley et.al., Int. J. Oral Implantology, 1:2 (1976).
  55.  “The Implantation of Natural Tooth Form Bioglasses in Baboons,” H. R. Stanley, L. L. Hench, R. Going, C. Bennett, S. J. Chellemi, C. King, N. Ingersoll, E. Ethridge, and K. Kreutziger, Oral Surg., Oral Med., Oral Pathology 45[5] (1976) 339-356.
  56.  “Histo-Chemical Responses at a Biomaterials Interface,” L. L. Hench and H. A. Paschall, J. Biomed. Mats. Res., No. 5 (Part 1) (1974) 49-64.
  57.  “Direct Chemical Bonding of Bioactive Glass-Ceramic Materials and Bone,” L. L. Hench and H. A. Paschall, J. Biomed. Mats. Res. Symp. No. 4 (1973) 25-42.